Australia markets close in 5 hours 22 minutes

WELL Health Technologies Corp. (W7V.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.6120+0.1120 (+4.48%)
At close: 05:02PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 637.80M
Enterprise value 897.25M
Trailing P/E 30.74
Forward P/E 12.85
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.06
Price/book (mrq)1.12
Enterprise value/revenue 1.58
Enterprise value/EBITDA 9.15

Trading information

Stock price history

Beta (5Y monthly) 1.24
52-week change 3-16.94%
S&P500 52-week change 329.31%
52-week high 33.8200
52-week low 32.3170
50-day moving average 32.4809
200-day moving average 32.6479

Share statistics

Avg vol (3-month) 3479
Avg vol (10-day) 31.01k
Shares outstanding 5245.76M
Implied shares outstanding 6255.12M
Float 8225.6M
% held by insiders 16.83%
% held by institutions 14.65%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3.52%
Operating margin (ttm)5.43%

Management effectiveness

Return on assets (ttm)2.02%
Return on equity (ttm)5.49%

Income statement

Revenue (ttm)838.19M
Revenue per share (ttm)3.50
Quarterly revenue growth (yoy)36.70%
Gross profit (ttm)N/A
EBITDA 97.24M
Net income avi to common (ttm)29.53M
Diluted EPS (ttm)0.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)48.23M
Total cash per share (mrq)0.2
Total debt (mrq)432.12M
Total debt/equity (mrq)48.62%
Current ratio (mrq)1.48
Book value per share (mrq)3.46

Cash flow statement

Operating cash flow (ttm)67.88M
Levered free cash flow (ttm)49.25M